Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression.

O'Brien RC, Abdallah K, Dong X, Hassanein M, Ji Q, Keskek SO, Lopez-Jaramillo P, Mehta R, Raef H, Tan K.

Open source

DOI
10.1111/1753-0407.70193
Published
2026-02-01
Container
J Diabetes
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1753-0407.70193,
  title = {Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression.},
  author = {O'Brien RC and  Abdallah K and  Dong X and  Hassanein M and  Ji Q and  Keskek SO and  Lopez-Jaramillo P and  Mehta R and  Raef H and  Tan K.},
  year = {2026},
  journal = {J Diabetes},
  doi = {10.1111/1753-0407.70193},
  url = {https://doi.org/10.1111/1753-0407.70193}
}

RIS

TY  - JOUR
TI  - Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression.
AU  - O'Brien RC
AU  -  Abdallah K
AU  -  Dong X
AU  -  Hassanein M
AU  -  Ji Q
AU  -  Keskek SO
AU  -  Lopez-Jaramillo P
AU  -  Mehta R
AU  -  Raef H
AU  -  Tan K.
PY  - 2026
JO  - J Diabetes
DO  - 10.1111/1753-0407.70193
UR  - https://doi.org/10.1111/1753-0407.70193
ER  - 

APA

RC, O., K, A., X, D., M, H., Q, J., SO, K., P, L., R, M., H, R., & K., T. (2026). Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression.. J Diabetes. https://doi.org/10.1111/1753-0407.70193

Source records